Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IKH-01 for Primary Dysmenorrhea
NCT00746096Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Sep 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in primary dysmenorrhea (PD) comparing IKH-01 Arm with Placebo Arm (2 arms). Primary endpoint: Patient Response to Treatment for Primary Dysmenorrhea (Difference of Total Dysmenorrhea Score) at 16 weeks. Started Sep 2008; status: completed.
02
Drugs
norethindrone + ethinyl estradiol
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT00746096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746096.